IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
Open Access
- 2 September 2020
- journal article
- research article
- Published by Taylor & Francis in RNA Biology
- Vol. 18 (3) , 391-403
Abstract
Epithelial-to-mesenchymal transition (EMT) is a hallmark of aggressive, mesenchymal-like high-grade serous ovarian carcinoma (HGSOC). The SRC kinase is a key driver of cancer-associated EMT promoting adherens junction (AJ) disassembly by phosphorylation-driven internalization and degradation of AJ proteins. Here, we show that the IGF2 mRNA-binding protein 1 (IGF2BP1) is up-regulated in mesenchymal-like HGSOC and promotes SRC activation by a previously unknown protein-ligand-induced, but RNA-independent mechanism. IGF2BP1-driven invasive growth of ovarian cancer cells essentially relies on the SRC-dependent disassembly of AJs. Concomitantly, IGF2BP1 enhances ERK2 expression in an RNA-binding dependent manner. Together this reveals a post-transcriptional mechanism of interconnected stimulation of SRC/ERK signalling in ovarian cancer cells. The IGF2BP1-SRC/ERK2 axis is targetable by the SRC-inhibitor saracatinib and MEK-inhibitor selumetinib. However, due to IGF2BP1-directed stimulation, only combinatorial treatment effectively overcomes the IGF2BP1-promoted invasive growth in 3D culture conditions as well as intraperitoneal mouse models. In conclusion, we reveal an unexpected role of IGF2BP1 in enhancing SRC/MAPK-driven invasive growth of ovarian cancer cells. This provides a rationale for the therapeutic benefit of combinatorial SRC/MEK inhibition in mesenchymal-like HGSOC.Keywords
All Related Versions
Funding Information
- Wilhelm-Roux (GRK1591)
This publication has 52 references indexed in Scilit:
- Emerging landscape of oncogenic signatures across human cancersNature Genetics, 2013
- IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)Nucleic Acids Research, 2013
- Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?Cellular and Molecular Life Sciences, 2012
- IGF2BP1 promotes cell migration by regulating MK5 and PTEN signalingGenes & Development, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Let‐7 modulates acquired resistance of ovarian cancer to TaxanesviaIMP‐1‐mediated stabilization of multidrug resistance 1International Journal of Cancer, 2011
- MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor mRNA Is Inhibited by the Coding Region Determinant-binding ProteinJournal of Biological Chemistry, 2010
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010
- CRD-BP Protects the Coding Region of βTrCP1 mRNA from miR-183-Mediated DegradationMolecular Cell, 2009
- Cooperative activation of Src family kinases by SH3 and SH2 ligandsCancer Letters, 2007